- April 2019
- EU General Court provides guidance to assess whether patent settlements between originator and generics infringe antitrust law (Servier)
- Paper on new governance procedures for medical devices in Italy
- Supplementary protection certificates: clarifications from the EU Court of Justice
- The Court of Milan on the urgent protection of patents infringed by products sold under the framework of a public tender
- Procedural issues in medical lawsuits
- A joint HMA and EMA taskforce analyzes the use of big data for the evaluation and monitoring of medicines
- Italian administrative court judgments on biosimilars
- Patient disease registries: potential use for regulatory purposes
- Personal Data: new interpretative recommendations in Clinical Trials
- February 2019
- Italian government approves a draft legislative decree amending italian legislation on clinical trials
- Using medicinal product trademarks in clinical trials prior to marketing authorization does not amount to genuine use, states advocate general szpunar
- New law to settle the long-lasting dispute on the pharmaceutical payback for 2013-2017
- No deal brexit’s impact on the pharmaceutical and medical devices industries: guidance from the ema and the european commission
- Benefit companies: an overview from a corporate perspective
- The european commission issues a recommendation on a european electronic health record exchange format
- The 2019 budget law restricts the scope of health services advertising
- Ema launched a public consultation on the key principles for electronic product information
- The european parliament legal affairs committee votes in favor of a comprehensive spc manufacturing waiver
- December 2017
- CJEU AND spcs: A NEVER-ENDING STORY
- Product information: ema starts digitization